{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:53:57Z","timestamp":1795100037565,"version":"4.10.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["212251_Z_18_Z"],"award-info":[{"award-number":["212251_Z_18_Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["857562"],"award-info":[{"award-number":["857562"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Brain ischemic stroke is among the leading causes of death and long-term disability. New treatments that alleviate brain cell damage until blood supply is restored are urgently required. The emerging focus of anti-stroke strategies has been on blood-brain-barrier permeable drugs that exhibit multiple sites of action. Here, we combine single-cell electrophysiology with live-cell imaging to find that \u03b2-Alanine (\u03b2-Ala) protects key physiological functions of brain cells that are exposed to acute stroke-mimicking conditions in ex vivo brain preparations. \u03b2-Ala exerts its neuroprotective action through several distinct pharmacological mechanisms, none of which alone could reproduce the neuroprotective effect. Since \u03b2-Ala crosses the blood-brain barrier and is part of a normal human diet, we suggest that it has a strong potential for acute stroke treatment and facilitation of recovery.<\/jats:p>","DOI":"10.1038\/s41419-022-05159-z","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T15:05:09Z","timestamp":1661785509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multi-target action of \u03b2-alanine protects cerebellar tissue from ischemic damage"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-3674","authenticated-orcid":false,"given":"Olga","family":"Kopach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-9947","authenticated-orcid":false,"given":"Dmitri A.","family":"Rusakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy","family":"Sylantyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"5159_CR1","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143:e254\u2013743.","journal-title":"Circulation."},{"key":"5159_CR2","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3324\/haematol.2019.219881","volume":"105","author":"S Staessens","year":"2020","unstructured":"Staessens S, Denorme F, Francois O, Desender L, Dewaele T, Vanacker P, et al. Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance. Haematologica. 2020;105:498\u2013507.","journal-title":"Haematologica."},{"key":"5159_CR3","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1001\/jama.2016.13647","volume":"316","author":"JL Saver","year":"2016","unstructured":"Saver JL, Goyal M, van der Lugt A, Menon BK, Majoie CB, Dippel DW, et al. Time to treatment with endovascular thrombectomy and outcomes from Ischemic stroke: a Meta-analysis. JAMA. 2016;316:1279\u201388.","journal-title":"JAMA."},{"key":"5159_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/156652408784221315","volume":"8","author":"DE Bredesen","year":"2008","unstructured":"Bredesen DE. Programmed cell death mechanisms in neurological disease. Curr Mol Med. 2008;8:173\u201386.","journal-title":"Curr Mol Med"},{"key":"5159_CR5","doi-asserted-by":"crossref","unstructured":"Clarke. PGH Apoptosis versus necrosis. In: Koliatsos VE, Ratan RR, editors. Cell death and diseases of the nervous System. Totowa, NJ: Humana Press; 1999. p. 3\u201328.","DOI":"10.1007\/978-1-4612-1602-5_1"},{"key":"5159_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.4161\/auto.20380","volume":"8","author":"PG Clarke","year":"2012","unstructured":"Clarke PG, Puyal J. Autophagic cell death exists. Autophagy. 2012;8:867\u20139.","journal-title":"Autophagy."},{"key":"5159_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/neu.2000.17.857","volume":"17","author":"GJ Zipfel","year":"2000","unstructured":"Zipfel GJ, Babcock DJ, Lee JM, Choi DW. Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J Neurotrauma. 2000;17:857\u201369.","journal-title":"J Neurotrauma"},{"key":"5159_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/nbdi.2002.0530","volume":"11","author":"Z Yu","year":"2002","unstructured":"Yu Z, Cheng G, Wen X, Wu GD, Lee W-T, Pleasure D. Tumor necrosis factor \u03b1 increases neuronal vulnerability to excitotoxic necrosis by inducing expression of the AMPA\u2013Glutamate receptor subunit GluR1 via an acid Sphingomyelinase- and NF-\u03baB-Dependent mechanism. Neurobiol Dis. 2002;11:199\u2013213.","journal-title":"Neurobiol Dis"},{"key":"5159_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4161\/auto.28264","volume":"10","author":"V Ginet","year":"2014","unstructured":"Ginet V, Spiehlmann A, Rummel C, Rudinskiy N, Grishchuk Y, Luthi-Carter R, et al. Involvement of autophagy in hypoxic-excitotoxic neuronal death. Autophagy. 2014;10:846\u201360.","journal-title":"Autophagy."},{"key":"5159_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","volume":"15","author":"NJ Maragakis","year":"2004","unstructured":"Maragakis NJ, Rothstein JD. Glutamate transporters: animal models to neurologic disease. Neurobiol Dis. 2004;15:461\u201373.","journal-title":"Neurobiol Dis"},{"key":"5159_CR11","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/35002090","volume":"403","author":"DJ Rossi","year":"2000","unstructured":"Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly by reversed uptake. Nature. 2000;403:316\u201321.","journal-title":"Nature."},{"key":"5159_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0306-4522(02)00370-6","volume":"115","author":"MC Grabb","year":"2002","unstructured":"Grabb MC, Lobner D, Turetsky DM, Choi DW. Preconditioned resistance to oxygen-glucose deprivation-induced cortical neuronal death: alterations in vesicular GABA and glutamate release. Neuroscience. 2002;115:173\u201383.","journal-title":"Neuroscience."},{"key":"5159_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09511","volume":"468","author":"AN Clarkson","year":"2010","unstructured":"Clarkson AN, Huang BS, MacIsaac SE, Mody I, Carmichael ST. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature. 2010;468:305.","journal-title":"Nature."},{"key":"5159_CR14","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/nm.2058","volume":"15","author":"DW Cope","year":"2009","unstructured":"Cope DW, Di Giovanni G, Fyson SJ, Orb\u00e1n G, Errington AC, Lorincz ML, et al. Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med. 2009;15:1392\u20138.","journal-title":"Nat Med"},{"key":"5159_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000049127","volume":"11","author":"E Mart\u00ednez-Vila","year":"2001","unstructured":"Mart\u00ednez-Vila E, Sieira PI. Current status and perspectives of neuroprotection in ischemic stroke treatment. Cerebrovasc Dis. 2001;11:60\u201370.","journal-title":"Cerebrovasc Dis"},{"key":"5159_CR16","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1001\/jama.285.13.1760","volume":"285","author":"F Plum","year":"2001","unstructured":"Plum F. Neuroprotection in acute ischemic stroke. JAMA. 2001;285:1760\u20131.","journal-title":"JAMA."},{"key":"5159_CR17","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(00)02326-6","volume":"355","author":"KR Lees","year":"2000","unstructured":"Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, et al. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet. 2000;355:1949\u201354.","journal-title":"Lancet."},{"key":"5159_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-018-0357-8","volume":"11","author":"QJ Wu","year":"2018","unstructured":"Wu QJ, Tymianski M. Targeting NMDA receptors in stroke: new hope in neuroprotection. Mol Brain. 2018;11:15.","journal-title":"Mol Brain"},{"key":"5159_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov. 2004;3:353\u20139.","journal-title":"Nat Rev Drug Discov"},{"key":"5159_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2174\/138161209787315594","volume":"15","author":"R Morphy","year":"2009","unstructured":"Morphy R, Rankovic Z. Designing multiple ligands - medicinal chemistry strategies and challenges. Curr Pharm Des. 2009;15:587\u2013600.","journal-title":"Curr Pharm Des"},{"key":"5159_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","volume":"9","author":"R Morphy","year":"2004","unstructured":"Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today. 2004;9:641\u201351.","journal-title":"Drug Discov Today"},{"key":"5159_CR22","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.1073\/pnas.1820799116","volume":"116","author":"AI Casas","year":"2019","unstructured":"Casas AI, Hassan AA, Larsen SJ, Gomez-Rangel V, Elbatreek M, Kleikers PWM, et al. From single drug targets to synergistic network pharmacology in ischemic stroke. Proc Natl Acad Sci USA 2019;116:7129\u201336.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5159_CR23","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1161\/STROKEAHA.111.618850","volume":"42","author":"GW Albers","year":"2011","unstructured":"Albers GW, Goldstein LB, Hess DC, Wechsler LR, Furie KL, Gorelick PB, et al. Stroke treatment academic industry roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies. Stroke. 2011;42:2645\u201350.","journal-title":"Stroke."},{"key":"5159_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.neuint.2010.06.001","volume":"57","author":"KE Tiedje","year":"2010","unstructured":"Tiedje KE, Stevens K, Barnes S, Weaver DF. Beta-alanine as a small molecule neurotransmitter. Neurochem Int. 2010;57:177\u201388.","journal-title":"Neurochem Int"},{"key":"5159_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1113\/jphysiol.2002.036459","volume":"548","author":"DJ Rossi","year":"2003","unstructured":"Rossi DJ, Hamann M, Attwell D. Multiple modes of GABAergic inhibition of rat cerebellar granule cells. J Physiol. 2003;548:97\u2013110.","journal-title":"J Physiol."},{"key":"5159_CR26","first-page":"97","volume":"27","author":"S Sangiah","year":"1985","unstructured":"Sangiah S. Effects of glycine and other inhibitory amino acid neurotransmitters on strychnine convulsive threshold in mice. Vet Hum Toxicol. 1985;27:97\u201399.","journal-title":"Vet Hum Toxicol"},{"key":"5159_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0197-0186(85)90037-3","volume":"7","author":"K Nakagawa","year":"1985","unstructured":"Nakagawa K, Huxtable RJ. The anticonvulsive actions of two lipophilic taurine derivatives. Neurochem Int. 1985;7:819\u201324.","journal-title":"Neurochem Int"},{"key":"5159_CR28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1046\/j.1471-4159.1996.67010330.x","volume":"67","author":"J Komura","year":"1996","unstructured":"Komura J, Tamai I, Senmaru M, Terasaki T, Sai Y, Tsuji A. Sodium and chloride ion-dependent transport of beta-alanine across the blood-brain barrier. J Neurochem. 1996;67:330\u20135.","journal-title":"J Neurochem"},{"key":"5159_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0014-5793(96)01366-X","volume":"400","author":"J Komura","year":"1997","unstructured":"Komura J, Tamai I, Senmaru M, Terasaki T, Sai Y, Tsuji A. Brain-to-blood active transport of beta-alanine across the blood-brain barrier. FEBS Lett. 1997;400:131\u20135.","journal-title":"FEBS Lett"},{"key":"5159_CR30","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.89.24.12145","volume":"89","author":"QR Liu","year":"1992","unstructured":"Liu QR, L\u00f3pez-Corcuera B, Nelson H, Mandiyan S, Nelson N. Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain. Proc Natl Acad Sci USA 1992;89:12145\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5159_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jss.2016.12.023","volume":"211","author":"L Brencher","year":"2017","unstructured":"Brencher L, Verhaegh R, Kirsch M. Attenuation of intestinal ischemia-reperfusion-injury by \u03b2-alanine: a potentially glycine-receptor mediated effect. J Surg Res. 2017;211:233\u201341.","journal-title":"J Surg Res"},{"key":"5159_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jss.2021.01.026","volume":"263","author":"L Dominowski","year":"2021","unstructured":"Dominowski L, Kirsch M. Synergistic effect of \u03b2-alanine and Aprotinin on mesenteric ischemia. J Surg Res. 2021;263:78\u201388.","journal-title":"J Surg Res"},{"key":"5159_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejbt.2020.04.003","volume":"45","author":"X Hou","year":"2020","unstructured":"Hou X, Sun G, Guo L, Gong Z, Han Y, Bai X. Cardioprotective effect of taurine and \u03b2-alanine against cardiac disease in myocardial ischemia and reperfusion-induced rats. Electron J Biotechnol. 2020;45:46\u201352.","journal-title":"Electron J Biotechnol"},{"key":"5159_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12970-015-0090-y","volume":"12","author":"ET Trexler","year":"2015","unstructured":"Trexler ET, Smith-Ryan AE, Stout JR, Hoffman JR, Wilborn CD, Sale C, et al. International society of sports nutrition position stand: beta-alanine. J Int Soc Sports Nutr. 2015;12:30.","journal-title":"J Int Soc Sports Nutr"},{"key":"5159_CR35","unstructured":"L\u00f8vik M, Fr\u00f8yland L, Haugen M, Henjum S, Stea TH, Strand TA, et al. Risk assessment of \u201cother substances\u201d \u2013 beta-alanine. opinion of the panel on nutrition, dietetic products, novel food and allergy of the Norwegian Scientific Committee for Food Safety. VKM report 2017: 13. VKM Report. 2017."},{"key":"5159_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12311-011-0331-9","volume":"11","author":"M Manto","year":"2012","unstructured":"Manto M, Bower JM, Conforto AB, Delgado-Garc\u00eda JM, da Guarda SN, Gerwig M, et al. Consensus paper: roles of the cerebellum in motor control-the diversity of ideas on cerebellar involvement in movement. Cerebellum. 2012;11:457\u201387.","journal-title":"Cerebellum."},{"key":"5159_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/archneur.1991.00530230086029","volume":"48","author":"JD Schmahmann","year":"1991","unstructured":"Schmahmann JD. An emerging concept: the cerebellar contribution to higher function. Arch Neurol. 1991;48:1178\u201387.","journal-title":"Arch Neurol"},{"key":"5159_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/0735-7044.100.4.443","volume":"100","author":"HC Leiner","year":"1986","unstructured":"Leiner HC, Leiner AL, Dow RS. Does the cerebellum contribute to mental skills? Behav Neurosci. 1986;100:443.","journal-title":"Behav Neurosci"},{"key":"5159_CR39","first-page":"386","volume":"13","author":"P Mari\u00ebn","year":"2014","unstructured":"Mari\u00ebn P, Ackermann H, Adamaszek M, Barwood CH, Beaton A, Desmond J, et al. Consensus paper: Language and the cerebellum: an ongoing enigma. Cerebellum. 2014;13:386\u2013410.","journal-title":"Cerebellum."},{"key":"5159_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12311-014-0627-7","volume":"14","author":"O Baumann","year":"2015","unstructured":"Baumann O, Borra RJ, Bower JM, Cullen KE, Habas C, Ivry RB, et al. Consensus paper: the role of the cerebellum in perceptual processes. Cerebellum. 2015;14:197\u2013220.","journal-title":"Cerebellum"},{"key":"5159_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/nature02442","volume":"428","author":"P Chadderton","year":"2004","unstructured":"Chadderton P, Margrie TW, H\u00e4usser M. Integration of quanta in cerebellar granule cells during sensory processing. Nature. 2004;428:856.","journal-title":"Nature."},{"key":"5159_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1113\/jphysiol.1969.sp008820","volume":"202","author":"D Marr","year":"1969","unstructured":"Marr D. A theory of cerebellar cortex. J Physiol. 1969;202:437\u201370.","journal-title":"J Physiol"},{"key":"5159_CR43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1098\/rstb.1992.0059","volume":"336","author":"T Tyrrell","year":"1992","unstructured":"Tyrrell T, Willshaw D. Cerebellar cortex: its simulation and the relevance of Marr\u2019s theory. Philos Trans R Soc Lond Ser B: Biol Sci. 1992;336:239\u201357.","journal-title":"Philos Trans R Soc Lond Ser B: Biol Sci"},{"key":"5159_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0025-5564(71)90051-4","volume":"10","author":"JS Albus","year":"1971","unstructured":"Albus JS. A theory of cerebellar function. Math Biosci. 1971;10:25\u201361.","journal-title":"Math Biosci"},{"key":"5159_CR45","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1113\/JP278745","volume":"598","author":"TD Sanger","year":"2020","unstructured":"Sanger TD, Yamashita O, Kawato M. Expansion coding and computation in the cerebellum: 50 years after the Marr-Albus codon theory. J Physiol. 2020;598:913\u201328.","journal-title":"J Physiol"},{"key":"5159_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/147342202753203087","volume":"1","author":"A Contestabile","year":"2002","unstructured":"Contestabile A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum. 2002;1:41\u201355.","journal-title":"Cerebellum."},{"key":"5159_CR47","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1113\/JP277626","volume":"597","author":"C McLaughlin","year":"2019","unstructured":"McLaughlin C, Clements J, Opri\u015foreanu AM, Sylantyev S. The role of tonic glycinergic conductance in cerebellar granule cell signalling and the effect of gain-of-function mutation. J Physiol. 2019;597:2457\u201381.","journal-title":"J Physiol"},{"key":"5159_CR48","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1093\/brain\/awh619","volume":"128","author":"M Hamann","year":"2005","unstructured":"Hamann M, Rossi DJ, Mohr C, Andrade AL, Attwell D. The electrical response of cerebellar Purkinje neurons to simulated ischaemia. Brain 2005;128:2408\u201320.","journal-title":"Brain"},{"key":"5159_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2017.03.005","volume":"131","author":"L Huang","year":"2017","unstructured":"Huang L, Wang C, Ge R, Ni H, Zhao S. Ischemia deteriorates spike encoding at cortical GABAergic neurons and cerebellar Purkinje cells by increasing the intracellular Ca(2). Brain Res Bull. 2017;131:55\u201361.","journal-title":"Brain Res Bull"},{"key":"5159_CR50","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1161\/01.STR.0000130990.28734.9c","volume":"35","author":"H Fujioka","year":"2004","unstructured":"Fujioka H, Kaneko H, Suzuki SS, Mabuchi K. Hyperexcitability-associated rapid plasticity after a focal cerebral ischemia. Stroke. 2004;35:e346\u2013348.","journal-title":"Stroke."},{"key":"5159_CR51","doi-asserted-by":"publisher","first-page":"14085","DOI":"10.1523\/JNEUROSCI.3572-11.2011","volume":"31","author":"MC Ding","year":"2011","unstructured":"Ding MC, Wang Q, Lo EH, Stanley GB. Cortical excitation and inhibition following focal traumatic brain injury. J Neurosci. 2011;31:14085\u201394.","journal-title":"J Neurosci"},{"key":"5159_CR52","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nprot.2013.075","volume":"8","author":"S Sylantyev","year":"2013","unstructured":"Sylantyev S, Rusakov DA. Sub-millisecond ligand probing of cell receptors with multiple solution exchange. Nat Protoc. 2013;8:1299\u2013306.","journal-title":"Nat Protoc"},{"key":"5159_CR53","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1007\/s11064-014-1245-y","volume":"39","author":"GAR Johnston","year":"2014","unstructured":"Johnston GAR. Muscimol as an ionotropic GABA receptor agonist. Neurochem Res. 2014;39:1942\u20137.","journal-title":"Neurochem Res"},{"key":"5159_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0920-1211(94)00066-6","volume":"20","author":"H Steve White","year":"1995","unstructured":"Steve White H, Harmsworth WL, Duane Sofia R, Wolf HH. Felbamate modulates the strychnine-insensitive glycine receptor. Epilepsy Res. 1995;20:41\u20138.","journal-title":"Epilepsy Res."},{"key":"5159_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1748-1716.1986.tb07938.x","volume":"127","author":"U Tossman","year":"1986","unstructured":"Tossman U, Jonsson G, Ungerstedt U. Regional distribution and extracellular levels of amino acids in rat central nervous system. Acta Physiologica Scandinavica. 1986;127:533\u201345.","journal-title":"Acta Physiologica Scandinavica"},{"key":"5159_CR56","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1046\/j.1471-4159.1995.65010454.x","volume":"65","author":"T Matsui","year":"1995","unstructured":"Matsui T, Sekiguchi M, Hashimoto A, Tomita U, Nishikawa T, Wada K. Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem. 1995;65:454\u20138.","journal-title":"J Neurochem"},{"key":"5159_CR57","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0306-4522(94)00597-X","volume":"66","author":"A Hashimoto","year":"1995","unstructured":"Hashimoto A, Oka T, Nishikawa T. Extracellular concentration of endogenous free D-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience 1995;66:635\u201343.","journal-title":"Neuroscience"},{"key":"5159_CR58","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s00726-016-2321-1","volume":"48","author":"SM Oh","year":"2016","unstructured":"Oh SM, Bhattarai JP, Han SK, Park SJ. Effects of hypotaurine on substantia gelatinosa neurons of the trigeminal subnucleus caudalis in immature mice. Amino Acids. 2016;48:2843\u201353.","journal-title":"Amino Acids"},{"key":"5159_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.1985.65.1.101","volume":"65","author":"AJ Hansen","year":"1985","unstructured":"Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiol Rev. 1985;65:101\u201348.","journal-title":"Physiol Rev"},{"key":"5159_CR60","doi-asserted-by":"crossref","unstructured":"van Beugen B, Gao Z, Boele H-J, Hoebeek F, De Zeeuw C. High frequency burst firing of granule cells ensures transmission at the parallel fiber to Purkinje cell synapse at the cost of temporal coding. Front Neural Circuits. 2013;7.","DOI":"10.3389\/fncir.2013.00095"},{"key":"5159_CR61","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1523\/JNEUROSCI.3175-11.2012","volume":"32","author":"AM Valera","year":"2012","unstructured":"Valera AM, Doussau F, Poulain B, Barbour B, Isope P. Adaptation of granule cell to Purkinje cell synapses to high-frequency transmission. J Neurosci. 2012;32:3267\u201380.","journal-title":"J Neurosci"},{"key":"5159_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1326-6-11","volume":"6","author":"TM Woodruff","year":"2011","unstructured":"Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011;6:11.","journal-title":"Mol Neurodegener"},{"key":"5159_CR63","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1161\/STROKEAHA.109.570424","volume":"41","author":"N Jaenisch","year":"2010","unstructured":"Jaenisch N, Witte OW, Frahm C. Downregulation of potassium chloride cotransporter KCC2 after transient Focal Cerebral Ischemia. Stroke. 2010;41:e151\u2013159.","journal-title":"Stroke."},{"key":"5159_CR64","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1523\/JNEUROSCI.0755-04.2004","volume":"24","author":"F Galeffi","year":"2004","unstructured":"Galeffi F, Sah R, Pond BB, George A, Schwartz-Bloom RD. Changes in intracellular chloride after Oxygen\u2013Glucose deprivation of the adult hippocampal slice: effect of Diazepam. J Neurosci. 2004;24:4478\u201388.","journal-title":"J Neurosci"},{"key":"5159_CR65","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/ecp.11.13","volume":"4","author":"CJ Van der Schyf","year":"2011","unstructured":"Van der Schyf CJ. The use of multi-target drugs in the treatment of neurodegenerative diseases. Expert Rev Clin Pharmacol. 2011;4:293\u20138.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"5159_CR66","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2007.11.075","volume":"1196","author":"J Hao","year":"2008","unstructured":"Hao J, Mdzinarishvili A, Abbruscato TJ, Klein J, Geldenhuys WJ, Van der Schyf CJ, et al. Neuroprotection in mice by NGP1-01 after transient focal brain ischemia. Brain Res. 2008;1196:113\u201320.","journal-title":"Brain Res"},{"key":"5159_CR67","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neulet.2005.03.042","volume":"383","author":"A Mdzinarishvili","year":"2005","unstructured":"Mdzinarishvili A, Geldenhuys WJ, Abbruscato TJ, Bickel U, Klein J, Van der Schyf CJ. NGP1-01, a lipophilic polycyclic cage amine, is neuroprotective in focal ischemia. Neurosci Lett. 2005;383:49\u201353.","journal-title":"Neurosci Lett"},{"key":"5159_CR68","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pneurobio.2018.12.004","volume":"175","author":"G Caruso","year":"2019","unstructured":"Caruso G, Caraci F, Jolivet RB. Pivotal role of carnosine in the modulation of brain cells activity: multimodal mechanism of action and therapeutic potential in neurodegenerative disorders. Prog Neurobiol. 2019;175:35\u201353.","journal-title":"Prog Neurobiol"},{"key":"5159_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0009-8981(94)90027-2","volume":"225","author":"WS Wassif","year":"1994","unstructured":"Wassif WS, Sherwood RA, Amir A, Idowu B, Summers B, Leigh N, et al. Serum carnosinase activities in central nervous system disorders. Clin Chim Acta. 1994;225:57\u201364.","journal-title":"Clin Chim Acta"},{"key":"5159_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fnut.2018.00070","volume":"5","author":"J Stautemas","year":"2018","unstructured":"Stautemas J, Everaert I, Lefevere FBD, Derave W. Pharmacokinetics of \u03b2-Alanine using different dosing strategies. Front Nutr. 2018;5:70.","journal-title":"Front Nutr"},{"key":"5159_CR71","doi-asserted-by":"crossref","unstructured":"Kopach O, Rybachuk O, Krotov V, Kyryk V, Voitenko N, Pivneva T. Maturation of neural stem cells and integration into hippocampal circuits - a functional study in an in situ model of cerebral ischemia. J Cell Sci. 2018;131.","DOI":"10.1242\/jcs.210989"},{"key":"5159_CR72","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fnins.2017.00388","volume":"11","author":"O Rybachuk","year":"2017","unstructured":"Rybachuk O, Kopach O, Krotov V, Voitenko N, Pivneva T. Optimized model of cerebral ischemia in situ for the long-lasting assessment of hippocampal cell death. Front Neurosci. 2017;11:388.","journal-title":"Front Neurosci"},{"key":"5159_CR73","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0165-0270(95)00133-6","volume":"64","author":"J Garthwaite","year":"1996","unstructured":"Garthwaite J, Batchelor AM. A biplanar slice preparation for studying cerebellar synaptic transmission. J Neurosci Methods. 1996;64:189\u201397.","journal-title":"J Neurosci Methods"},{"key":"5159_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/jpet.111.185124","volume":"340","author":"YA Blednov","year":"2012","unstructured":"Blednov YA, Benavidez JM, Homanics GE, Harris RA. Behavioral characterization of knockin mice with mutations M287L and Q266I in the glycine receptor alpha1 subunit. J Pharmcol Exp Ther. 2012;340:317\u201329.","journal-title":"J Pharmcol Exp Ther"},{"key":"5159_CR75","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0091-3057(91)90562-G","volume":"40","author":"MG Corda","year":"1991","unstructured":"Corda MG, Orlandi M, Lecca D, Carboni G, Frau V, Giorgi O. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol Biochem Behav. 1991;40:329\u201333.","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05159-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05159-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T16:05:45Z","timestamp":1661789145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05159-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":75,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["5159"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05159-z","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"18 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"747"}}